Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Think Research Corporation V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical... see more

TSXV:THNK - Post Discussion

Think Research Corporation > Investor relations rating
View:
Post by Possibleidiot01 on Feb 08, 2024 4:25pm

Investor relations rating

Hamburglar48 , thenks for finding that clinic closing tidbit ; it's one of a few questions I've been attempting to get answers to for all year,essentially .

I've been  asking questions and failing to get answers which rarely happens when I contact the investor relations dept of a company so ,I'm posting this comment in hopes that somebody from the company reads our posts which I feel in unlikely but hey , you never know.

Here's a partial text of my third e mail attempt

'I took the time to listen to the call , tried to enter the queue by pressing star 1 , to get some questions answered and some further clarifications and it didn't work.

So here are some of  my questions.

Going back to April 25,2022 ,the first agreement with Beedie Capital ,was the company thinking the whole amount would be eventually utilized or just partially used?

 Why has the company failed to get revenues and costs more balanced? They mentioned the closure in St. Louis realizing a $2 million savings ( most of which seems to have been captured?) but only a 1% and 5% decline in opex over the 3 month and 9 month period. Rationalizing costs was mentioned as the focus for the 9 months so why has nothing changed? What are the further levers the company can pull on?

They mentioned clinic services - one was closed , guessing St. Louis and one was sold. I would like to know what was sold even if it was immaterial?

Does the company still own the bariatic services clinic?

Of the $28 million owed to Bank of Nova Scotia and Beedie Capital , how much is owed to the Bank of Nova Scotia?

Can you explain exactly what is meant by third party agreements?

On average , how much does Pharmapod cost a clinic?

I'm willing to have a discussion if that suits you  better. Just let me know.

Thanks"

I have made  three e mails personally and now I'm up to four voice mails ( the last one, just now) with no response.

I even had an investment professional forward my e mail almost two weeks ago , thinking a professional e mail might get a response , with no response so far.

Here's what happens when you phone them  @ 1-416-388-7119 : makes you wonder if one of their cost savings was Investor Relations?

You call the number and then after a few rings , voicemail picks up but with no identifer, it's actually the phone of Mark Sakamoto.
The last few days , I've tried corporate HQ which offers two basic options - company directory A-Z or Z-A and reception. If you try the directory , you get the same two individuals in both directions and then nothing.
Reception gets you the mailbox which is full.
This is an exercise in futility.

Sad to be posting this but this needs to be improved.
THE WORST IR ever?




Comment by dt_core on Feb 08, 2024 8:14pm
The dreadfully poor IR is yet another unforced error by the management team. Easy wins such as responding to IR inquiries, having updated investor materials on the website (the PowerPoint hasn't been updated in almost a year), all go towards building trust and credibility with investors and ultimately help support your share price. Yet management is acting like serving shareholder interests is ...more  
Comment by zinger99 on Feb 16, 2024 8:16am
Your MBO comment was well stated. Hard to accept a .32 buy-out. Looks like they have locked in 48 percent of the vote. I would have preferred a much higher take out price per share. Looks good only because the purchase was done at a horrible time in the share price. 
Comment by dt_core on Feb 16, 2024 8:29am
Well there you have it. I knew something had to give by mid month and dissapointed to see that my concern about an MBO has now come to fruition. So how should shareholder vote? We've had poor disclosure and also what now appears to be false and misleading statement by management during conference calls, and a management team that is trying to save their hides (jobs) after destroying ...more  
Comment by zinger99 on Feb 16, 2024 8:57am
It would be great to see another party enter the fray. Well Health would be great. However, the NR indicates 48 percent of shareholders have agreed to the Beedie offer. Wish we had seen the big contract deals that were hinted at by the CEO a number of quarters ago.  I will not vote in favour of the takeout. 
Comment by Possibleidiot01 on Feb 16, 2024 8:59am
"I am quite certain that Beedie expects to make out like bandits on this deal" That's the one sure thing here. Maybe somebody should try to figure out if 32 cents actually represents a premium to the the existing options ; the latest of which were done at 0.2688. Previous ones done at 35 cents and above. My brain isn't up to this at this time. My suspicision is that the touted ...more  
Comment by zinger99 on Feb 16, 2024 9:29am
Thanks. I missed the Go-shop provision. They also need 2/3 S/H support for the .32 deal.  Go-Shop Provision – the Arrangement Agreement includes a go-shop provision, during which time the Company, with the assistance of Canaccord, will be permitted to actively solicit, evaluate and enter into negotiations with respect to a potential Superior Proposal (as defined in the Arrangement ...more  
Comment by dt_core on Feb 16, 2024 9:49am
To put this deal into perspective it values the entire company, including debt, at an enterprise value of $76 million. That is rock bottom low valuation (0.8x 2024 sales!). I've done the math assuming that higher bids may trigger Beedie conversion, so with that in mind a 1.0x EV/2024 Sales multiple wold imply a stock price of 0.50 cents. I would expect bidders like Well as being more than ...more  
Comment by dt_core on Feb 16, 2024 9:54am
100% Canadian :)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities